Loading company details...
Beta
Latest Form 4 (Jul 16, 2026): Charles David Pauza (Chief Science Officer Virology): Grant/Award of 97,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 16, 2026 | Charles David Pauza, Chief Science Officer Virology | Grant/Award | 97,000 | n/a |
| Jul 16, 2026 | Werner Cautreels | Grant/Award | 14,150 | n/a |
| Jul 15, 2026 | Nikolay Savchuk, Chief Operating Officer | Grant/Award | 93,000 | n/a |
| Jul 15, 2026 | Jack E. Stover | Grant/Award | 14,150 | n/a |
| Jul 15, 2026 | Iain D. Dukes, Chief Executive Officer | Grant/Award | 274,000 | n/a |
| Jul 15, 2026 | Robert Redfield, Chief Medical Officer | Grant/Award | 84,000 | n/a |
| Jul 15, 2026 | Charles Nolan Parker, Chief Financial Officer | Grant/Award | 90,000 | n/a |
| Jul 15, 2026 | Mary Teresa Shoemaker | Grant/Award | 14,150 | n/a |
| Jul 15, 2026 | Trafford Clarke | Grant/Award | 14,150 | n/a |
| Jul 15, 2026 | John Harold Leaman | Grant/Award | 14,150 | n/a |